State Street’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Sell |
3,355,678
-253,973
| -7% | -$2.42M | ﹤0.01% | 1929 |
|
|
2025
Q1 | $37.8M | Sell |
3,609,651
-107,732
| -3% | -$1.13M | ﹤0.01% | 1793 |
|
|
2024
Q4 | $87.6M | Buy |
3,717,383
+75,524
| +2% | +$1.78M | ﹤0.01% | 1418 |
|
|
2024
Q3 | $131M | Buy |
3,641,859
+440,890
| +14% | +$15.8M | 0.01% | 1171 |
|
|
2024
Q2 | $113M | Sell |
3,200,969
-992,584
| -24% | -$35M | ﹤0.01% | 1183 |
|
|
2024
Q1 | $119M | Buy |
4,193,553
+1,856,412
| +79% | +$52.7M | 0.01% | 1197 |
|
|
2023
Q4 | $31.1M | Buy |
2,337,141
+398,499
| +21% | +$5.3M | ﹤0.01% | 1959 |
|
|
2023
Q3 | $17.4M | Buy |
1,938,642
+158,902
| +9% | +$1.42M | ﹤0.01% | 2244 |
|
|
2023
Q2 | $20M | Buy |
1,779,740
+1,178,928
| +196% | +$13.3M | ﹤0.01% | 2247 |
|
|
2023
Q1 | $6.92M | Buy |
600,812
+24,669
| +4% | +$284K | ﹤0.01% | 2861 |
|
|
2022
Q4 | $6.68M | Sell |
576,143
-2,737
| -0.5% | -$31.7K | ﹤0.01% | 2906 |
|
|
2022
Q3 | $7.35M | Buy |
578,880
+19,192
| +3% | +$244K | ﹤0.01% | 2870 |
|
|
2022
Q2 | $3.85M | Buy |
559,688
+58,717
| +12% | +$403K | ﹤0.01% | 3223 |
|
|
2022
Q1 | $4.83M | Buy |
500,971
+8,618
| +2% | +$83.1K | ﹤0.01% | 3198 |
|
|
2021
Q4 | $5.85M | Buy |
492,353
+7,593
| +2% | +$90.3K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $7.87M | Buy |
484,760
+25,864
| +6% | +$420K | ﹤0.01% | 3009 |
|
|
2021
Q2 | $9.66M | Buy |
458,896
+231,492
| +102% | +$4.87M | ﹤0.01% | 2937 |
|
|
2021
Q1 | $3.53M | Buy |
227,404
+5,400
| +2% | +$83.9K | ﹤0.01% | 3197 |
|
|
2020
Q4 | $4.66M | Buy |
+222,004
| New | +$4.66M | ﹤0.01% | 3000 |
|